Lv1
50 积分 2023-01-10 加入
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
16小时前
已完结
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
17小时前
已完结
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
18小时前
已完结
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
19小时前
已完结
Imaging features of neurosyphilis
9天前
已完结
Cancer incidence and mortality in China, 2022
24天前
已完结
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
9个月前
已完结
皖公网安备34019202002308
